Literature DB >> 28496712

The Concept of "Burden" in Atrial Fibrillation.

Gregg F Rosner1, James A Reiffel1, Kathleen Hickey1.   

Abstract

Over the last decade or so the term "burden" has become frequently encountered in manuscripts discussing atrial fibrillation (AF). AF "burden" is perhaps most commonly encountered in the electrophysiological context - the amount of time the patient is in AF out of the total monitored time (i.e., the percent of time one is in AF). However, "burden" in AF may also be used in other contexts, which we characterize below as "disease burden", "clinical burden," "economic burden." Over the course of the disease progression and its therapy, such "burdens" may change, and may do so in parallel with each other or in opposite directions. This manuscript explores these various concepts of AF "burden" so as to emphasize to authors and readers that when using the term, its meaning must be made clear.

Entities:  

Year:  2012        PMID: 28496712      PMCID: PMC5153001          DOI: 10.4022/jafib.400

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  15 in total

Review 1.  The cost of illness of atrial fibrillation: a systematic review of the recent literature.

Authors:  S E Wolowacz; M Samuel; V K Brennan; J-G Jasso-Mosqueda; I C Van Gelder
Journal:  Europace       Date:  2011-07-14       Impact factor: 5.214

2.  2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Valentin Fuster; Lars E Rydén; Davis S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; G Neal Kay; Jean-Yves Le Huezey; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; L Samuel Wann
Journal:  J Am Coll Cardiol       Date:  2011-03-15       Impact factor: 24.094

Review 3.  Atrial fibrillation, arrhythmia burden and thrombogenesis.

Authors:  Chee W Khoo; Suresh Krishnamoorthy; Hoong Sern Lim; Gregory Y H Lip
Journal:  Int J Cardiol       Date:  2011-07-02       Impact factor: 4.164

4.  The burden of atrial fibrillation in the Netherlands.

Authors:  H E Heemstra; R Nieuwlaat; M Meijboom; H J Crijns
Journal:  Neth Heart J       Date:  2011-09       Impact factor: 2.380

Review 5.  Quality of life in patients with atrial fibrillation: a systematic review.

Authors:  Graham Thrall; Deirdre Lane; Douglas Carroll; Gregory Y H Lip
Journal:  Am J Med       Date:  2006-05       Impact factor: 4.965

6.  Atrial arrhythmia burden as an endpoint in clinical trials: is it the best surrogate? Lessons from a multicenter defibrillator trial.

Authors:  David E Euler; Paul A Friedman
Journal:  Card Electrophysiol Rev       Date:  2003-12

7.  The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.

Authors:  Taya V Glotzer; Emile G Daoud; D George Wyse; Daniel E Singer; Michael D Ezekowitz; Christopher Hilker; Clayton Miller; Dongfeng Qi; Paul D Ziegler
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-08-04

8.  Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation.

Authors:  Anna Ringborg; Robby Nieuwlaat; Peter Lindgren; Bengt Jönsson; Dogan Fidan; Aldo P Maggioni; Jose Lopez-Sendon; Janina Stepinska; Dennis V Cokkinos; Harry J G M Crijns
Journal:  Europace       Date:  2008-03-07       Impact factor: 5.214

Review 9.  Update on atrial fibrillation: part I.

Authors:  Irina Savelieva; John Camm
Journal:  Clin Cardiol       Date:  2008-02       Impact factor: 2.882

Review 10.  The worldwide social burden of atrial fibrillation: what should be done and where do we go?

Authors:  Massimo Santini; Renato P Ricci
Journal:  J Interv Card Electrophysiol       Date:  2007-03-20       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.